Long Non-Coding RNA TP73-AS1 Promotes the Development of Lung Cancer by Targeting the miR-27b-3p/LAPTM4B Axis

Qingfeng Jiang1, Wenqun Xing1, Jinhua Cheng1

  • 1Department of Thoracic Surgery, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan, People's Republic of China.

Abstract

Insights

Long non-coding RNA TP73-AS1 promotes lung cancer progression by regulating the miR-27b-3p/LAPTM4B axis. This finding suggests TP73-AS1 as a potential diagnostic and therapeutic target for lung cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in cancer development.
  • The specific function of TP73 antisense RNA 1T (TP73-AS1) in lung cancer remains largely unexplored.

Purpose of the Study:

  • To investigate the role of TP73-AS1 in lung cancer progression.
  • To elucidate the molecular mechanism underlying TP73-AS1's function in lung cancer, including its interaction with microRNA-27b-3p (miR-27b-3p) and lysosomal-associated protein transmembrane-4 Beta (LAPTM4B).

Main Methods:

  • Quantitative real-time polymerase chain reaction (qRT-PCR) to measure gene expression.
  • Cellular assays (MTT, Annexin V-FITC/PI, Transwell) to assess proliferation, apoptosis, migration, and invasion.
  • In vivo tumor xenograft models.
  • Luciferase reporter assays to confirm molecular interactions.
  • Western blot analysis for protein expression.

Main Results:

  • TP73-AS1 expression was significantly upregulated in lung cancer tissues and cells.
  • TP73-AS1 depletion inhibited lung cancer cell growth and metastasis in vitro and tumor growth in vivo.
  • TP73-AS1 functions as an endogenous sponge for miR-27b-3p, with an inverse correlation observed between their expression.
  • miR-27b-3p directly targets LAPTM4B, and this axis is co-regulated by TP73-AS1.

Conclusions:

  • TP73-AS1 promotes lung cancer progression via the miR-27b-3p/LAPTM4B regulatory axis.
  • TP73-AS1 represents a potential biomarker for lung cancer diagnosis and a therapeutic target.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.9K